Antidepressants for smoking cessation

Cited by (1,000)

Items 401–500 of 1,000

1. Smoking cessation interventions for in‐patients: a selective review with recommendations for hospital‐based health professionals
   Luke Wolfenden, Elizabeth M. Campbell, Raoul A. Walsh, John Henry Wiggers · 2003 · Drug and Alcohol Review
2. Non-nicotine pharmacotherapies for smoking cessation
   Hayden J. McRobbie, Mi-Suen Lee, Z. Juniper · 2005 · Respiratory Medicine
3. Antagonistes des r??cepteurs de l???angiotensine II
   Pierre L. Corvol, Pierre‐François Plouin · 2002 · Drugs
4. Do financial incentives for delivering health promotion counselling work? Analysis of smoking cessation activities stimulated by the quality and outcomes framework
   Coleman, Tim · 2010 · BMC Public Health
5. Reaching Healthy People 2010 by 2013
   David Theodore Levy, Patricia L. Mabry, Amanda L. Graham, C. Tracy Orleans, David B. Abrams · 2010 · American Journal of Preventive Medicine
6. New directions in the genetic mechanisms underlying nicotine addiction
   Marcus Robert Munafo, Elaine C Johnstone, Michael F.G. Murphy, Robert T. Walton · 2001 · Addiction Biology
7. Bupropion and nicotine patch as smoking cessation aids in alcoholics
   Kathleen M. Grant, Stephanie Sinclair Kelley, Lynette M. Smith, Sangeeta Agrawal, James R. Meyer, Debra J. Romberger · 2007 · Alcohol
8. Alcohol and Substance Use in Liver Transplant Patients
   Andrea DiMartini, Catherine C Crone, Mary Amanda Dew · 2011 · Clinics in Liver Disease
9. Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment
   Peter Olausson, Pernilla Åkesson, Jörgen A. Engel, Bo Söderpalm · 2001 · European Journal of Pharmacology
10. Tobacco Addiction
    Peter L. Selby, Laurie A. Zawertailo · 2022 · New England Journal of Medicine
11. Effectiveness of tobacco use cessation interventions delivered by pharmacy personnel: A systematic review
    Noreen Dadirai Mdege, Stanley Chindove · 2013 · Research in Social and Administrative Pharmacy
12. Smoking cessation interventions for pulmonary tuberculosis treatment outcomes
    Kathiresan Jeyashree, Soundappan Kathirvel, Hemant Deepak Shewade, Harpreet Kaur, Sonu Goel · 2016 · Cochrane Database of Systematic Reviews
13. Combination Therapies for Smoking Cessation
    Windle, Sarah B., Filion, Kristian B., Mancini, Joseph G., Adye-White, Lauren, Joseph, Lawrence, Gore, Genevieve C., Habib, Bettina, Grad, Roland, Pilote, Louise, Eisenberg, Mark J. · 2016 · American Journal of Preventive Medicine
14. Variability and effectiveness of comparator group interventions in smoking cessation trials: a systematic review and meta‐analysis
    Nicola Black, Maarten C. Eisma, Wolfgang Viechtbauer, Marie Johnston, Robert West, Jamie Hartmann‐Boyce, Susan Michie, Marijn de Bruin · 2020 · Addiction
15. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians
    Daniel Kotz, Edwin J. Wagena, Geertjan Wesseling · 2006 · Respiratory Medicine
16. Smoking cessation: How compelling is the evidence? A review
    Philip Tønnesen · 2009 · Health Policy
17. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes
    Elad Lerer, Kyra Kanyas, Osnat Karni, Richard P. Ebstein, Bernard Lerer · 2006 · Molecular Psychiatry
18. Comparison of the Effectiveness of Varenicline and Combination Nicotine Replacement Therapy for Smoking Cessation in Clinical Practice
    Leonie S. Brose, Robert West, John Stapleton · 2013 · Mayo Clinic Proceedings
19. Pharmacotherapy of Substance Use Disorders
    Jane B. Acri, Phil Skolnick · 2013 · Oxford University Press eBooks
20. Smoking cessation strategies for patients with asthma: improving patient outcomes
    Perret, Jennifer, Boneveski, Billie, McDonald, Christine, Abramson, Michael · 2016 · Journal of Asthma and Allergy
21. New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?
    Emma Beard, Lion Shahab, Damian M. Cummings, Susan Michie, Robert West · 2016 · CNS Drugs
22. Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews
    Jonathan Livingstone‐Banks, Nicola Lindson, Jamie Hartmann‐Boyce, Paul N Aveyard · 2021 · Addiction
23. Serotonergic mechanisms in addiction-related memories
    Bríd Á. Nic Dhonnchadha, Kathryn A. Cunningham · 2008 · Behavioural Brain Research
24. Efficacy and Tolerability of Pharmacotherapies to Aid Smoking Cessation in Adolescents
    Steffani R. Bailey, Erin Crew, Emily C. Riske, Seth D. Ammerman, Thomas N. Robinson, Joel D. Killen · 2012 · Pediatric Drugs
25. Cost-effectiveness of an Intensive Smoking Cessation Intervention for COPD Outpatients
    Lieke C.A. Christenhusz, Rilana Prenger, Marcel E. Pieterse, Erwin R. Seydel, Job A.M. van der Palen · 2011 · Nicotine & Tobacco Research
26. Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines
    Victor I. Reus, B. J. Smith · 2008 · International Journal of Clinical Practice
27. Effectiveness of dentist's intervention in smoking cessation: A review
    Carlos Javier Omaña Cepeda, Enric Jané Salas, Albert Estrugo‐Devesa, Eduardo Chimenos Küstner, J Lopez-Lopez · 2015 · Journal of Clinical and Experimental Dentistry
28. Pharmacologic Treatment of Perinatal Depression
    Mary Kimmel, Elizabeth Cox, Crystal Edler Schiller, Edith Gettes, Samantha E Meltzer-Brody · 2018 · Obstetrics and Gynecology Clinics of North America
29. Systematic Review of the Literature on Postpartum Care: Effectiveness of Interventions for Smoking Relapse Prevention, Cessation, and Reduction in Postpartum Women
    Cheryl A. Levitt, Elizabeth Ann Shaw, Sharon S.-L. Wong, Janusz A. Kaczorowski · 2007 · Birth
30. The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus
    Stamatina Driva, Aliki Korkontzelou, Serena Tonstad, Nikolaοs Tentolouris, Paraskevi A Katsaounou · 2022 · International Journal of Environmental Research and Public Health
31. GENETIC STUDY: Association between dopamine transporter genotypes and smoking cessation: a meta‐analysis
    John Stapleton, Gay Sutherland, Colin OʼGara · 2007 · Addiction Biology
32. Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms
    Takeo Ishii, Ritsuko Wakabayashi, Hiroko Kurosaki, Akihiko Gemma, Kozui Kida · 2010 · Journal of Human Genetics
33. Exploring Scenarios to Dramatically Reduce Smoking Prevalence: A Simulation Model of the Three-Part Cessation Process
    David Theodore Levy, Patricia L. Mabry, Amanda L. Graham, C. Tracy Orleans, David B. Abrams · 2010 · American Journal of Public Health
34. Use of antidepressants and risk of lung cancer
    Sengwee Toh, Luis Alberto García Rodríguez, Sonia Hernández–Dı́az · 2007 · Cancer Causes & Control
35. Review of smoking cessation treatments for people with mental illness
    Jonathan Campion, Ken Checinski, Jo Nurse · 2008 · Advances in Psychiatric Treatment
36. General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: Impact after 1year of two complex interventions
    Sander R. Hilberink, J. Jacobs, MARINUS H. M. BRETELER, Hein de Vries, Richard P.T.M. Grol · 2010 · Patient Education and Counseling
37. Effectiveness of a telephone delivered and a face-to-face delivered counseling intervention for smoking cessation in patients with coronary heart disease: a 6-month follow-up
    Nadine C. Berndt, Catherine A. W. Bolman, Erika Sivarajan Froelicher, Aart N. Mudde, Math J. J. M. Candel, Hein de Vries, Lilian Lechner · 2013 · Journal of Behavioral Medicine
38. Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care records
    Laura Douglas, Lisa C Szatkowski · 2013 · BMC Public Health
39. Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision
    Lisa C Szatkowski, Paul N Aveyard · 2015 · British Journal of General Practice
40. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
    Ewoud Schuit, Orestis A. Panagiotou, Marcus Robert Munafo, Derrick Bennett, Andrew W. Bergen, Sean P. David · 2017 · Cochrane Database of Systematic Reviews · Retracted
41. Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence
    Ronald C. Hogg · 2015 · Nicotine & Tobacco Research
42. The prospects for immunotherapy in smoking cessation
    Wayne Hall · 2002 · The Lancet
43. Pharmacotherapy for smoking cessation: present and future
    Aubin, Henri-Jean, Karila, Laurent, Reynaud, Michel · 2011 · Current Pharmaceutical Design
44. Cytisine for smoking cessation: A systematic review and meta-analysis
    Sandra Ofori, Clara Lu, Omotola O Olasupo, Brittany Burns Dennis, Nadia S. Fairbairn, Philip James Devereaux, Lawrence C. E. Mbuagbaw · 2023 · Drug and Alcohol Dependence
45. Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association
    Kim G. E. Smolderen, Zainab Samaan, Carole Decker, Tracie C. Collins, Ronald M. Lazar, Nathan K. Itoga, Carlos Mena‐Hurtado · 2023 · Circulation
46. Smoking Use and Cessation Among People with Serious Mental Illness.
    Aniyizhai Annamalai, Noreen Singh, Stephanie S. O’Malley · 2015 · PubMed Central
47. Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study
    Kyla Anne McKay, Helen L. Tremlett, John D. Fisk, Scott Burton Patten, Kirsten Marie Fiest, Lindsay I. Berrigan, Ruth Ann Marrie, for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) · 2015 · Multiple Sclerosis Journal
48. Emerging drugs for the treatment of tobacco dependence: 2014 update
    Muhamad Y. Elrashidi, Jon O. Ebbert · 2014 · Expert Opinion on Emerging Drugs
49. The Value of Elderly Disease Prevention
    Dana P. Goldman, David Cutler, Baoping Shang, Geoffrey Joyce · 2006 · Forum for Health Economics & Policy
50. Smoking Cessation and the Cardiovascular Specialist: Canadian Cardiovascular Society Position Paper
    Andrew Pipe, Mark Jeffrey Eisenberg, Anil Kumar Gupta, Robert D. Reid, Neville Suskin, James A. Stone · 2011 · Canadian Journal of Cardiology
51. Pharmacogenetics of smoking cessation therapy
    Gustavo Lucena Kortmann, Cristina Jaureguy Dobler, Lisiane Bizarro, Claiton H.D. Bau · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
52. Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?
    Ashare, Rebecca L., Lerman, Caryn, Tyndale, Rachel F., Hawk, Larry W., George, Tony P., Cinciripini, Paul, Schnoll, Robert A. · 2017 · Journal of Smoking Cessation
53. Mechanism-based medication development for the treatment of nicotine dependence
    Zheng‐Xiong Xi, Krista J. Spiller, Eliot L. Gardner · 2009 · Acta Pharmacologica Sinica
54. Bupropion SR for the treatment of smokeless tobacco use
    Lowell C. Dale, Jon O. Ebbert, Elbert D. Glover, Ivana T. Croghan, Darrell R. Schroeder, Herbert H. Severson, R. Douglas Hurt · 2007 · Drug and Alcohol Dependence
55. Varenicline as compared to bupropion in smoking-cessation therapy—Cost–utility results for Sweden 2003
    Kristian Bolin, Ann‐Christin Mörk, Stefan Willers, Björn Lindgren · 2008 · Respiratory Medicine
56. Bupropion Sustained Release for Treatment of Tobacco Dependence
    James Taylor Hays, Jon O. Ebbert · 2003 · Mayo Clinic Proceedings
57. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy: Comparison of varenicline and NRT
    Kralikova, Eva, Kmetova, Alexandra, Stepankova, Lenka, Zvolska, Kamila, Davis, Rachel, West, Robert · 2013 · Addiction
58. Targeting the Noradrenergic System for Gender-Sensitive Medication Development for Tobacco Dependence
    Terril L. Verplaetse, Andrea H. Weinberger, P. H. Smith, Kelly Cosgrove, Yann S. Mineur, Marina R. Picciotto, Carolyn M. Mazure, Sherry A. McKee · 2015 · Nicotine & Tobacco Research
59. Therapeutic advances in the treatment of nicotine addiction: present and future
    Giuseppina Casella, Pasquale Caponnetto, Riccardo Polosa · 2010 · Therapeutic Advances in Chronic Disease
60. Smoking Cessation, Depression, and Exercise: Empirical Evidence, Clinical Needs, and Mechanisms
    Paquito Bernard, Grégory Ninot, Grégory Moullec, Sébastien Guillaume, Philippe Courtet, Xavier Quantin · 2013 · Nicotine & Tobacco Research
61. A systematic review of the effectiveness of smoking cessation interventions among patients with tuberculosis.
    E. Whitehouse, J. Lai, J. Golub, Jason E. Farley · 2018 · Public Health Action
62. Acupuncture for smoking cessation: A systematic review and meta-analysis of 24 randomized controlled trials
    Jian-Hua Wang, Robbert A. van Haselen, Mei Wang, Guanlin Yang, Zhe Zhang, Maria Friedrich, Yu Wang, Ya-Qiang Zhou, Mei Yin, Cheng-Yu Xiao et al. · 2019 · Tobacco Induced Diseases
63. Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline
    James Taylor Hays, Jon O. Ebbert, Amit Sood · 2009 · Mayo Clinic Proceedings
64. Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease
    Edwin J. Wagena, Maurice P. Zeegers, Onno C. P. van Schayck, Emiel F.�M. Wouters · 2003 · Drug Safety
65. Effect of Cessation Interventions on Hookah Smoking: Post-Hoc Analysis of a Cluster-Randomized Controlled Trial
    Omara F. Dogar, Mohammed Jawad, Sarwat Shah, James Nicholas Newell, Mona N Kanaan, Muhammad Amjad Khan, Kamran Siddiqi · 2013 · Nicotine & Tobacco Research
66. A randomized controlled trial of a smoking cessation intervention conducted among prisoners
    ROBYN L. RICHMOND, Devon Indig, Tony Gerard Butler, Kay A Wilhelm, Vicki Archer, ALEX D. WODAK · 2012 · Addiction
67. In-hospital smoking cessation programs: what do VA patients and staff want and need?
    Sonia A. Duffy, Pamela J. Reeves, Christopher Hermann, Carrie A Karvonen-Gutierrez, Patricia M. Smith · 2008 · Applied Nursing Research
68. Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal
    Rebecca L. Ashare, Heath D. Schmidt · 2014 · Expert Opinion on Drug Discovery
69. Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
    Allison B. Gold, Caryn E. Lerman · 2012 · Human Genetics
70. Improving the effectiveness of tobacco use cessation (TUC)
    Ian G. Needleman, Vivian I. Binnie, Anja Ainamo, Alan B. Carr, Angela Fundak, Anne Koeber, Kerstin Öhrn, J. P. Rosseel · 2010 · International Dental Journal
71. Impact and Duration of Brief Surgeon-Delivered Smoking Cessation Advice on Attitudes Regarding Nicotine Dependence and Tobacco Harms for Patients with Peripheral Arterial Disease
    Karina S. Newhall, Bjoern Dominik Suckow, Emily L. Spangler, Benjamin S. Brooke, Andres S. Schanzer, Tze‐Woei Tan, Mary Burnette, Maria Orlando Edelen, Alik M. Farber, Philip P. Goodney · 2016 · Annals of Vascular Surgery
72. CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in Smokers
    Sufang Li, Yihong Yang, Ewa B. Hoffmann, Rachel Fynvola Tyndale, Elliot A. Stein · 2016 · Biological Psychiatry
73. Management of Crohn’s disease in smokers: Is an alternative approach necessary?
    Pilar Nos · 2011 · World Journal of Gastroenterology
74. A randomized trial of short psychotherapy versus sustained‐release bupropion for smoking cessation
    Gerald Zernig, Reinhild Wallner, Ursula Grohs, Norbert Kriechbaum, Georg Kemmler, Alois Saria · 2008 · Addiction
75. Promoting smoking cessation
    Michele Larzelere, Dave E. Williams · 2005 · BDJ
76. The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial
    Philippe Hoogsteder, Daniel Kotz, P.I. van Spiegel, Wolfgang Viechtbauer, Ruth Brauer, Paul Kessler, Matthew W. Kalnik, Raafat E.F. Fahim, Onno C. P. van Schayck · 2012 · BMC Public Health
77. Interventions to Address Chronic Disease and HIV: Strategies to Promote Smoking Cessation Among HIV-infected Individuals
    RAYMOND S. NIAURA, Geetanjali Chander, Heidi E. Hutton, Cassandra A. Stanton · 2012 · Current HIV/AIDS Reports
78. What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
    Daniel Kotz, Marcus J. H. Huibers, Robert West, Geertjan Wesseling, Onno C. P. van Schayck · 2009 · Patient Education and Counseling
79. Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area
    Huibert D. Mansvelder, Zara M. Fagen, Ben Chang, Robert D. Mitchum, Daniel S. McGehee · 2007 · Biochemical Pharmacology
80. The current state of tobacco cessation treatment
    Humberto Choi, Jorge Ataucuri-Vargas, Charlie Lin, Amanda M. Singrey · 2021 · Cleveland Clinic Journal of Medicine
81. Tobacco smoking cessation management: integrating varenicline in current practice
    Laurence M Galanti · 2008 · Vascular Health and Risk Management
82. Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial
    Daniel Kotz, Geertjan Wesseling, Marcus J. H. Huibers, Onno C. P. van Schayck · 2007 · BMC Public Health
83. Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
    Candice E. Van Skike, Sarah E. Maggio, Anna R. Reynolds, Erin M. Casey, Michael Thomas Bardo, Linda P. Dwoskin, Mark Prendergast, Kimberly Nixon · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
84. Life-style Modification in Peripheral Arterial Disease
    Shaheen Ali Khan, Marcus Cleanthis, Jonathan D Smout, Marcus D Flather, Gerard P Stansby · 2004 · European Journal of Vascular and Endovascular Surgery
85. Pharmacotherapy of tobacco dependence
    Arunabh Talwar, Mukesh Jain, V K Vijayan · 2004 · Medical Clinics of North America
86. Smoking, periodontal disease and the role of the dental profession
    KK Hilgers, D. F. Kinane · 2004 · International Journal of Dental Hygiene
87. A Double-blind, Placebo-Controlled, Randomized Trial of Bupropion for Smoking Cessation in Primary Care
    Roldano Fossati · 2007 · Archives of Internal Medicine
88. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation
    Adam Matthew Leventhal, Sean P. David, Molly Brightman, David R. Strong, John E. McGeary, Richard A. Brown, Elizabeth E. Lloyd‐Richardson, Marcus Robert Munafo, George R. Uhl, RAYMOND S. NIAURA · 2010 · The Pharmacogenomics Journal
89. Smoking Cessation Interventions in Clinical Practice
    Jacques Cornuz · 2007 · European Journal of Vascular and Endovascular Surgery
90. An Internet Survey of Use, Opinions and Preferences for Smoking Cessation Medications: Nicotine, Varenicline, and Bupropion
    Jean‐François Etter, Nina G. Schneider · 2012 · Nicotine & Tobacco Research
91. A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation
    Nicky J. Welton, Elaine C Johnstone, Sean P. David, Marcus Robert Munafo · 2008 · Nicotine & Tobacco Research
92. Management of secondary risk factors in patients with intermittent claudication
    Kevin Cassar, R. Coull, Paul Bachoo, Ewan Macaulay, Julie Brittenden · 2003 · European Journal of Vascular and Endovascular Surgery
93. Metabolism and biochemical effects of nicotine for primary care providers
    Christine Noel Metz, Peter K. Gregersen, Anil K. Malhotra · 2004 · Medical Clinics of North America
94. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion
    Sean P. David, David R. Strong, Adam Matthew Leventhal, Molly Lancaster, John E. McGeary, Marcus Robert Munafo, Andrew W. Bergen, Gary E. Swan, Neal L. Benowitz, Rachel Fynvola Tyndale et al. · 2013 · Addiction
95. Varenicline
    Gillian M. Keating, Katherine Ann Lyseng-Williamson · 2010 · PharmacoEconomics
96. Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens
    Ben Chang, Claire A. Daniele, Keith Gallagher, Michelle Madonia, Robert D. Mitchum, Lindy E. Barrett, Paul Vezina, Daniel S. McGehee · 2011 · Journal of Neurophysiology
97. Varenicline: New treatment with efficacy in smoking cessation
    Victor I. Reus, Ronald Scott Obach, Jotham W. Coe, Hélène M. Faessel, Hans Rollema, Eric J. Watsky, Karen R. Reeves · 2007 · Drugs of today
98. The Role of Depression in the Uptake and Maintenance of Cigarette Smoking
    Janet E. Audrain-McGovern, Adam Matthew Leventhal, David R. Strong · 2015 · International review of neurobiology
99. The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice
    Monzurul Amin Roni, Shafiqur Rahman · 2014 · Psychopharmacology
100. Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: Recent preclinical and clinical insights
     Neil E. Paterson · 2008 · European Journal of Pharmacology